Save the NIH from Sequestration

A biomedical advocacy group asks Congress to protect the National Institutes of Health from the $2.5 billion cut that may be coming down the pike.

Oct 24, 2012
Dan Cossins

WIKIMEDIA, POCO A POCOIf Congress fails to approve a plan to reduce the federal budget deficit by 1.2 trillion before January 2, 2013, federal agencies, including those responsible for funding life science researchers, will suffer automatic budget cuts—known as “sequestration”.

With that prospect looming, the California Healthcare Institute (CHI)—a non-profit advocacy group for the state’s biomedical research industry—has pleaded with Congress to ringfence the estimated $2.5 billion that would be slashed from the National Institutes of Health (NIH) budget. Such a reduction would seriously damage the Californian economy and compromise scientific innovation across the United States, the CHI argues in a letter addressed to political leaders of both parties.

The CHI also stated that the success of California's life science industry—which employs some 270,000 workers, pays more than $20 billion in wages every year, and accounts for $18.6 billion in global exports, according to the CHI letter—is the result of a combination of funding from the NIH and venture capitalists. Sequestration puts that partnership at risk and would result in at least 2,000 fewer funded research grants.

The cuts would not only impact researchers, but also the businesses that supply them with instruments, the CHI argued. In an article in Xconomy, CHI President and CEO David Gollaher claimed that the cuts would damage the national economy. He cited research from United for Medical Research, a coalition seeking to increase funding to NIH, that estimated 33,000 job losses and a $4.5 billion drop in economic activity should the NIH budget get cut by sequestration.

“The continued vibrancy of the California and U.S. biomedical industry depends on many things,” the letter read. “But at its very foundation, it depends upon continued advances and progress in science that are fueled and driven by the NIH and other federally-funded science research.”

(Hat tip to GenomeWeb)

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets


Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!